Résumé
Although nearly two-third of bankruptcy in the United States is medical in origin, a common assumption is that individuals facing a potentially lethal disease opt for cure at any cost. This assumption has never been tested, and knowledge of how the American population values a trade-off between cure and bankruptcy is unknown.
Mots-clés
discrete choice analysishealth care costsmedical bankruptcy;
Référence
M.G Shrime, M.C. Weinstein, James K. Hammitt, Jessica Cohen et Joshua Salomon, « Trading Bankruptcy for Health: A Discrete-Choice Experiment », Value in Health, vol. 21, n° 1, janvier 2018, p. 95–104.
Voir aussi
Publié dans
Value in Health, vol. 21, n° 1, janvier 2018, p. 95–104